##croi2025
LightNews LightNews
gtt-vih.bsky.social
La Noticia del Día de @gTtVIH #CROI2025 Pitavastatina es una opción segura para mejorar la salud cardiovascular en personas mayores con el VIH, sin afectar a la función cognitiva ni aumentar la fragilidad física
www.gtt-vih.org/publicacione...
La Noticia del Día de @gTtVIH #CROI2025 Pitavastatina es una opción segura para mejorar la salud cardiovascular en personas mayores con el VIH, sin afectar a la función cognitiva ni aumentar la fragil...
La Noticia del Día de @gTtVIH #CROI2025 Pitavastatina es una opción segura para mejorar la salud cardiovascular en personas mayores con el VIH, sin afectar a la función cognitiva ni aumentar la fragil...
www.gtt-vih.org
May 28, 2025 at 12:07 PM
hiv-i-base.bsky.social
It shows that integrase inhibitor-based ART can sometimes still be used after viral failure on injectable cabotegravir/rilpivirine and it links to an excellent presentation by Prof Saye Khoo at #CROI2025.

@therexuol.bsky.social
May 24, 2025 at 12:43 PM
medscapefrancais.bsky.social
VIH : pas de retard de développement du langage chez les enfants exposés à la PrEP in utero #CROI2025
http://ms.spr.ly/63328SwIlI
VIH : pas de retard de développement du langage chez les enfants exposés à la PrEP in utero
L’utilisation de la PrEP par les femmes enceintes ou allaitantes à risque de contracter le VIH est-elle sûre pour leur futur enfant ? Après la publication d’études sur l'innocuité de la PrEP in utero, de nouvelles données sont disponibles concernant le développement du langage de l'enfant à 5 ans.
ms.spr.ly
May 16, 2025 at 11:20 AM
medscapefrancais.bsky.social
Des symptômes de COVID-19 plus graves en cas d'antécédent de cancer
#CROI2025
http://ms.spr.ly/63328SpH50
Des symptômes de COVID-19 plus graves en cas d'antécédent de cancer
Les adultes ayant survécu à un cancer sont plus susceptibles de rapporter des symptômes graves de covid que la population générale, d'après les données d'une nouvelle étude portant sur près de 9 000 personnes aux États-Unis.
ms.spr.ly
May 5, 2025 at 1:15 PM
thewellprojecthiv.bsky.social
Now more than ever, it is critical to reserve dedicated time and effort to consider updates in #HIV care and research among providers, researchers, community members, and allies. To read about Bridgette's experiences at #CROI2025, click here > www.thewellproject.org/news-press/a... #thewellproject
Activism, Care, Community, and Cure: An Overview of CROI 2025
Challenges, changes, and cancellation of funding cannot truly suppress the brilliance and determination of the scientists, researchers, and community members that are striving toward improving the liv...
www.thewellproject.org
May 2, 2025 at 6:20 PM
pozmagazine.bsky.social
More #CROI2025 news: Body mass index alone may be a poor measure of heart disease risk in people with HIV, underscoring the importance of screening for excess visceral abdominal fat. Waist circumference is a good indicator.

www.poz.com/article/bmi-...
BMI May Underestimate Cardiovascular Risk in People With HIV
A new formulation of Egrifta, which is easier to administer, may help reduce visceral fat and improve metabolic health.
www.poz.com
May 1, 2025 at 2:24 AM
hiv-i-base.bsky.social
RIO study Q&A: i-base.info/htb/50971

- What is the #RIOstudy and how does it work?
- What are #bNAbs?
- What are the results and what do they mean?
- Has someone been cured of #HIV?

#CROI2025 #BHIVA25 #RIOtrial #HIVsky #ResearchSky #HIVcure #HIVresearch #HIVtreatment riotrial.bsky.social
Colourful i-Base image. The Rio Study Q&A. The heading in dark blue text on a light blue background reads: The RIO Study. Q and A is in large lettering, each a different bright colour on a coloured block. Main text, also in dark blue, reads: Read our Q&A for a breakdown of exciting results from this HIV cure-related study. White text on a small, tilted square graphic on the right, reads: HTB news. 2025. HIV treatment, prevention, access, and more. This block is made up of smaller blocks, coloured, dark blue, red, teal, orange and mustard. The logos for CROI and BHIVA are at the bottom of the image.
April 24, 2025 at 10:59 AM
lizhighleyman.bsky.social
#CROI2025 abstracts and session webcasts are now available to the public. Lots of good HIV & COVID content this year.

www.croiconference.org/croi-2025-re...
April 22, 2025 at 7:41 PM
hiv-i-base.bsky.social
#CROI2025: Rebecca Denison gives opening community talk on 40 years of #HIV: i-base.info/htb/50824

“There are still people after all these years who wonder if it would be better to die than have people find out they have HIV. We need to change that.”

#HIVwomen #EndAIDS2030 #SaveForeignAid #HIVsky
i-Base graphic. The main text in red and dark blue, on a light blue blue background, reads: CROI 2025. 40+ years of HIV. Community talk highlights experiences of women living with HIV. Below, in white on a burnt orange background, text reads, San Francisco, California. 9th to 12th March. On top of this is a faint image of the Golden Gate Bridge. In the top right corner is a photo of Rebecca Denison, a white woman with short brown hair. She is holding open her jacket to reveal her t-shirt, which reads, "It's a coup." In the top left corner is a URL: I hyphen base dot info.
April 17, 2025 at 8:01 PM
meredithw.bsky.social
The Abstract eBook, session recordings (webcasts), and additional materials from the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) are now publicly accessible at CROI 2025 Resources –
www.croiconference.org/croi-2025-re...
#CROI2025
CROI 2025 Resources
www.croiconference.org
April 17, 2025 at 1:37 AM
taghivscience.bsky.social
#CROI2025 webcasts of all sessions now publicly available www.croiwebcasts.org
CROI Webcasts
www.croiwebcasts.org
April 15, 2025 at 1:33 PM
uclachipts.bsky.social
UPDATE! The #ICYMI session was previously postponed and is now confirmed for Monday, April 21, 2025, at 2 PM PT. We encourage folks to register and learn about key abstracts from #CROI2025 selected by CHIPTS scientists. Register: tinyurl.com/mr24ds2v
April 14, 2025 at 9:42 PM
hiv-i-base.bsky.social
Potential vaccine-like effect from bNAbs for African women who started ART in acute infection:

i-base.info/htb/50674

6/20 women were able to remain off-ART at week 48, with 4 still off-ART.

#HIV #CROI2025 #HIVsky #IDsky #Medsky #ResearchSky #HIVresearch #SouthAfrica @ahri-news.bsky.social
i-Base graphic. The main text in red and dark blue, on a light blue blue background, reads: CROI 2025. First HIV cure-related study in South African women. Potential vaccine-like effect from bNAbs. Below, in white on a burnt orange background, text reads, San Francisco, California. 9th to 12th March. On top of this is a faint image of the Golden Gate Bridge. In the top left corner is a URL: I hyphen base dot info. In the top right corner is a box made of blue, yellow and red blocks. White text on it reads, HTB news. 2025.
April 10, 2025 at 6:34 PM
miamalan.bsky.social
The 6-monthly anti #HIV jab, #lenacapavir, can end #Aids in SA by 2032 — but only if between 2 and 4-million HIV-negative people use it every year over the next 8 years. But how much will it cost? I break it down. #Croi2025 bhekisisa.org/health-news-...
The 6-monthly anti-HIV jab could end Aids in SA by 2032 - Bhekisisa
A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...
bhekisisa.org
April 9, 2025 at 7:58 AM
lizhighleyman.bsky.social
More news from #CROI2025. A functional cure for HIV is not around the corner, but promising results like these underscore the need for continued research.
pozmagazine.bsky.social POZ Magazine @pozmagazine.bsky.social · Apr 8
Broadly neutralizing antibodies appeared to help keep HIV under control after stopping antiretroviral therapy & may play a role in long-term remission, according to two studies presented at #CROI2025, one of which enrolled African women who bear the brunt of the global epidemic.
Can Broadly Neutralizing Antibodies Keep HIV in Remission?
Specialized HIV-fighting antibodies might one day be part of a strategy for a functional cure.
www.poz.com
April 8, 2025 at 9:35 PM
pozmagazine.bsky.social
Broadly neutralizing antibodies appeared to help keep HIV under control after stopping antiretroviral therapy & may play a role in long-term remission, according to two studies presented at #CROI2025, one of which enrolled African women who bear the brunt of the global epidemic.
Can Broadly Neutralizing Antibodies Keep HIV in Remission?
Specialized HIV-fighting antibodies might one day be part of a strategy for a functional cure.
www.poz.com
April 8, 2025 at 9:26 PM
crankyqueer.bsky.social
Great session at #CROI2025 last month on #menopause in people living with #HIV. I was happy to cover it for TheBodyPRO.com.

www.thebodypro.com/hiv/menopaus...
Menopause in Women Living With HIV: Update From CROI 2025
For people living with HIV assigned female at birth, menopausal status is a highly relevant but often overlooked factor in quality of life, comorbidities, and even immunological dynamics.
www.thebodypro.com
April 6, 2025 at 11:59 PM
longcovidsupport.bsky.social
If you’re interested in what’s been happening in #LongCovid research, take a look at this 🧵 by @longcovidphysio.bsky.social on the ‘Conference on Retroviruses & Opportunistic Infections’ that took place in March. ⬇️

#CROI2025
longcovidphysio.bsky.social Long COVID Physio @longcovidphysio.bsky.social · Mar 29
#CROI is the Conference on Retroviruses and Opportunistic Infections

This year #CROI2025 was in San Francisco, USA. Data on #LongCOVID was presented.

So what was the latest science for the field of infection associated chronic conditions?

A thread 🧵
April 2, 2025 at 3:23 PM
myhelfy.bsky.social
In a way, this is the conundrum @drlaurajwaters.bsky.social and I tried to navigate in our latest podcast, which focused on #CROI2025 highlights and takeaways. Here's that, if you'd like to listen/read - the balance is hard to strike, and feedback is welcome!

www.thebodypro.com/hiv/future-h...

/4
HIV Clinical Highlights From CROI 2025
Laura Waters, M.D., and Myles Helfand recap several noteworthy moments and clinically important studies from the 2025 Conference on Retroviruses and Opportunistic Infections.
www.thebodypro.com
April 2, 2025 at 2:19 PM
hiv-i-base.bsky.social
#Lenacapavir as #HIV #PrEP – yearly injections safe and well-tolerated

i-base.info/htb/50575

The phase 1 results also show that they achieved higher drug concentrations in plasma than 6-monthly injections.

A phase 3 study is already planned.

#CROI2025 #LEN #HIVsky #Medsky #IDsky
i-Base graphic. The main text in red and dark blue, on a light blue blue background, reads: CROI 2025. Lenacapavir as PrEP. Exciting potential for once-yearly injections. Below, in white on a burnt orange background, text reads, San Francisco, California. 9th to 12th March. On top of this is a faint image of the Golden Gate Bridge. In the top left corner is a URL: I hyphen base dot info. In the top right corner is a box made of blue, yellow and red blocks. White text on it reads, HTB news. 2025.
April 2, 2025 at 1:32 PM
sebpoule.bsky.social
HIV 🇨🇦 Perspectives
Breaking News from CROI San Francisco
#CROI2025

Tuesday April 1, English
Thursday April 3, Français

Join us ! #IDsky #HIVsky
March 31, 2025 at 9:49 PM
tristanjbarber.bsky.social
@bhiva.bsky.social Best of #CROI2025 Feedback Session Number 1 has kicked off! If you don't catch it tonight then you can register for session 2 on Wednesday. Excellent summary sessions followed by Live Q&A

bhiva.org/event/bhiva-...

🤩👏👍
March 31, 2025 at 5:23 PM
rockefeller.edu
Results presented at #CROI2025 from a collaboration between the #NussenzweigLab and colleagues at @imperialcollegeldn.bsky.social and @ox.ac.uk show that two broadly neutralizing antibodies can keep HIV suppressed for months. #RockefellerScience
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication - News
If the past four decades have taught us anything about HIV, it’s to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ha...
www.rockefeller.edu
March 31, 2025 at 1:55 PM
longcovidphysio.bsky.social
#CROI is the Conference on Retroviruses and Opportunistic Infections

This year #CROI2025 was in San Francisco, USA. Data on #LongCOVID was presented.

So what was the latest science for the field of infection associated chronic conditions?

A thread 🧵
March 29, 2025 at 2:54 PM
pozmagazine.bsky.social
A growing body of research confirms that taking the antibiotic doxycycline after sex—an approach known as doxyPEP—reduces the risk of STIs. Two studies at #CROI2025 looked at longer-term use in the city that rolled it out first.
Studies Show Longer-Term Benefits of doxyPEP for STI Prevention
San Francisco clinic sees significant drop in sexually transmitted infections despite low adherence to doxycycline prophylaxis over time.
www.poz.com
March 28, 2025 at 6:32 PM